Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers

Michael E. Rothenberg, Michael Tagen, Jae H. Chang, Janel M. Boyce‐Rustay, Michel Friesenhahn, David H. Hackos, Avis Hains, Dan Sutherlin, M. Renee Ward, William C. Cho

Clinical Drug Investigation · 2019 · 47 citations · 25 references

Concepts

References

25